Manufacturing

Investment Job Creation Labor Relations Safety Regulations Production Sites Product Control Production Issues Supply Chain Domestic Production Trade Policies Tariffs Environmental Issues RayzeBio Inc Investments Drug Production

3 ARTICLES

4w ago

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

The pharmaceutical giant will build seven new facilities and a $1.1 billion research hub in San Diego, aiming to bolster domestic drug production and create thousands of jobs.

3 ARTICLES

4w ago

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion

Manufacturing

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

Sanofi Employees Protest Planned Sale of Amilly Factory

Sanofi Indicted Over Toxic Emissions at Mourenx Plant

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

French Government Seeks Job Guarantees in Sanofi's Doliprane Sale

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion